ClinicalTrials.gg
RecruitingNCT04886895Updated Nov 12, 2026

Motor Training for Infants With Cerebral Palsy

An interventional study of Let's Move Motor Intervention in Cerebral Palsy, sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 1 site in United States. Open to participants aged 3 Months to 8 Months. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2022; still recruiting 4 years 10 months later.
Updated Nov 12, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
3 Months to 8 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Planned enrollment
115th of 296
35 · median 25
Started
2022
with 24 others
No phase
218 of 372
49 open now
Primary completion
2027-12
later than 58 of 101 live
Registered
229th of 372
by date
Lead sponsor
7 of 372
Children's Hospital Medical Center, Cincinnati

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 115th largest by planned enrollment of the 296 interventional ones that give a count, is one of 25 that started in 2022, is one of 218 with no phase, reaches primary completion later than 58 of the 101 other live ones, and was the 229th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

69 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 3 Months to 8 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

The intervention in this study, Let's Move, is a motor intervention for infants at risk for cerebral palsy. We will test the feasibility and acceptability of the intervention as well as preliminary effectiveness.

Read the detailed description

The aims of this study are to test the feasibility, acceptability, and operationalize a novel motor intervention, called "Let's Move" delivered using a combined clinic and home (video telehealth) therapy model.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • motor skills
  • occupational therapy
  • physical therapy
04

Who can participate

Ages eligible
3 Months to 8 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age at enrollment: between 3-8 months corrected age
  • Caregivers fluent in English
  • Preterm infants with objectively defined severe diffuse white matter abnormality on MRI at term OR
  • High-risk infants (e.g., preterm, neonatal hypoxic-ischemic encephalopathy, perinatal stroke) with moderate-severe injury on structural MRI or cranial ultrasound (e.g., basal ganglia/thalamic signal intensity, cystic periventricular leukomalacia, encephalomalacia, large stroke, and/or severe intraventricular/periventricular hemorrhage) at around term-equivalent age or before Neonatal Intensive Care Unit discharge AND either:

    • "Absent" fidgety movements based on the Prechtl General Movement Assessment (GMA) between 3-4 months corrected age OR
    • A score of 56 or below on the Hammersmith Infant Neuromotor Examination (HINE) between 3-6 months corrected age (31)

Exclusion criteria

Exclusion Criteria:

  • Medical conditions that restrict active participation such as oxygen dependence
  • Infants with significant visual deficits defined by the inability to track an object horizontally
  • Living in a remote location prohibiting drives to the hospital every other week.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
35 participants (estimated)

Study arms

  • Active comparator
    Control group

    Infants randomized to the usual care arm will receive usual care for 4 months. Therapy services provided to infants at this age vary in terms of frequency, location, and provider. Usual care is prescribed by the child's primary care provider (PCP), and in this population, usual care typically consists of one or both of the following: Early intervention therapy services provided by the state or Therapy in an outpatient clinic. Control group participants will be offered the Let's Move interventions after 16 weeks of control group.

    Other: Let's Move Motor Intervention

  • Experimental
    Intervention group: Let's Move

    Infants randomized to the Let's Move intervention group will be scheduled for therapy one time per week for 16 sessions (approximately 30-60 minutes per session). The intervention setting will involve both in-person (CCHMC clinic or in-home) and telehealth (in-home, video-based) sessions. The therapist will provide the caregivers with home programs to complete between therapy sessions (5 days per week). The home program will be based on the infant's goals set collaboratively between the caregiver and the evaluating therapist at the baseline assessment using the Canadian Occupational Performance Measure (COPM). At least half of the intervention sessions will be video recorded to assess feasibility and monitor intervention fidelity.

    Other: Let's Move Motor Intervention

Interventions

  • OtherLet's Move Motor Intervention

    Let's Move intervention will be administered and videotaped with infant/caregiver dyads. Therapy will occur weekly (30-60 minutes per session) for 16 weeks, alternating between clinic and home (video telehealth) sessions. Each month, we will attempt to schedule two clinic-based sessions followed by 2 telehealth-based sessions

06

What researchers measure

Primary outcomes

  1. Change on Peabody Developmental Scales - Second Edition before and after intervention and follow-up

    Motor test

    Time frame: Baseline,16 weeks, 28 weeks

Secondary outcomes

  1. Change on Pediatric Evaluation of Disability Inventory-Computer Adaptive Test before and after intervention and follow-up

    Parent reported test for functional performance

    Time frame: Baseline,16 weeks, 28 weeks

  2. Change on Canadian Occupational Performance Measure before and after intervention and follow-up

    Caregivers perception of child's performance on functional goals

    Time frame: Baseline,16 weeks, 28 weeks

  3. Change on Hammersmith Infant Neurological Exam before and after intervention and follow-up

    Neurological exam

    Time frame: Baseline,16 weeks, 28 weeks

  4. Preverbal visual assessment (PreViAs

    Screening tool for the development of visual maturation

    Time frame: Enrollment, 4 months later, 8 months later

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Dec 2027, 70 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 70 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

Primary completion moved once since we started tracking on Sep 25, 2026: Jan 2027 → Dec 2027, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2021
First posted
May 14, 2021
StartActual
Jan 7, 2022
Primary completionEst.
Dec 1, 2027was Jan 2027
CompletionEst.
Jan 1, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 1, 2027→Dec 1, 2027
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Jan 1, 2027→Dec 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04886895
Responsible party
Karen Harpster (Associate Professor, Children's Hospital Medical Center, Cincinnati) — Principal investigator
First posted
May 14, 2021
Start date
Jan 7, 2022
Primary completion
Dec 1, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Karen Harpster, PhD, OTR/L
Contact
karen.harpster@cchmc.org
513-803-3604
Nehal A Parikh, DO, MS
Contact
nehal.parikh@cchmc.org
513-517-1044
Karen Harpster, PhD, OTR/L
principal investigator · Children's Hospital Medical Center, Cincinnati

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion